According to the lawsuit, throughout the Class Period, the Company and its senior executives misled investors and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, ...
The fund gained 0.43% for the fourth quarter, ahead of the 0.33% result of the Russell 2000® Index. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback